Venous Thromboembolism
Tranexamic acid did not seem to increase risk of postoperative complications in patients undergoing total joint arthroplasty.
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
MPN-associated vascular thromboembolisms were more common in JAK2-mutated diseases and less common in CALR-mutated diseases.
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH.
Patients with severe LMWH are less likely to experience VTE.
In the 30-day period following consultation or hospitalization for gout flares, a transient increase in the rate of ...
According to authors of a recent study, venous thromboembolism (VTE) is the third most common cardiovascular disease. ...
According to a study published in Lancet, the optimal dose of low-molecular-weight heparin for venous thromboembolism ...
In the ORAL Surveillance study, researchers found tofacitinib showed a higher incidence of pulmonary embolism compared ...
Advertisement
Expert Interviews on Hematology
Advertisement
